PGRMC1 and type 2 diabetes mellitus: Although fatty livers are typically associated with insulin resistance [40], the metabolic benefit conferred by skeletal Pgrmc1 loss outweighed the potential disadvantage from hepatic Pgrmc1 loss, thereby ameliorating systemic insulin resistance in T2D PKO mice (Figure S8).